XML 20 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash Flows from Operating Activities:      
Net Income (Loss) $ (416,000,000) $ 181,000,000 $ (983,000,000)
Adjustments required to reconcile net income to cash flows from operating activities:      
Depreciation and amortization 460,000,000 495,000,000 611,000,000
Contract Inducement Amortization 3,000,000 2,000,000 2,000,000
Goodwill impairment 0 0 935,000,000
Deferred income taxes (75,000,000) (230,000,000) (160,000,000)
(Gain) loss from investments (2,000,000) (10,000,000) (7,000,000)
Amortization of debt financing costs 11,000,000 9,000,000 0
(Gain) loss on extinguishment of debt 108,000,000 0 0
(Gain) loss on divestitures and transaction costs 42,000,000 (42,000,000) 2,000,000
Stock-based compensation 38,000,000 40,000,000 23,000,000
(Increase) decrease in accounts receivable 133,000,000 31,000,000 (23,000,000)
(Increase) decrease in other current and long-term assets (111,000,000) (32,000,000) (96,000,000)
Increase (decrease) in accounts payable and accrued compensation (56,000,000) (49,000,000) (60,000,000)
Increase (decrease) in restructuring liabilities 8,000,000 34,000,000 27,000,000
Increase (decrease) in other current and long-term liabilities 161,000,000 (125,000,000) (210,000,000)
Net change in income tax assets and liabilities (17,000,000) 11,000,000 39,000,000
Other operating, net (4,000,000) (15,000,000) (5,000,000)
Net cash provided by (used in) operating activities 283,000,000 300,000,000 95,000,000
Cash Flows from Investing Activities:      
Cost of additions to land, buildings and equipment (179,000,000) (96,000,000) (149,000,000)
Proceeds from sale of land, buildings and equipment 13,000,000 33,000,000 0
Cost of additions to internal use software (45,000,000) (36,000,000) (39,000,000)
Proceeds from investments 1,000,000 117,000,000 11,000,000
Proceeds from divestitures and sale of assets, net of cash 675,000,000 56,000,000 (54,000,000)
Net proceeds on notes receivable 0 0 248,000,000
Other investing, net (5,000,000) 0 (1,000,000)
Net cash provided by (used in) investing activities 460,000,000 74,000,000 16,000,000
Cash Flows from Financing Activities:      
Proceeds on long-term debt 0 306,000,000 1,969,000,000
Debt issuance fee payments (3,000,000) (8,000,000) (67,000,000)
Payments on debt (519,000,000) (241,000,000) (32,000,000)
Premium on debt redemption (95,000,000) 0 0
Net payments to former parent company 0 (161,000,000) (1,720,000,000)
Taxes paid for settlement of stock based compensation (10,000,000) (5,000,000) 0
Dividends paid on preferred stock (10,000,000) (10,000,000) 0
Other financing 0 (5,000,000) 0
Net cash provided by (used in) financing activities (637,000,000) (124,000,000) 150,000,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash (8,000,000) 1,000,000 (6,000,000)
Increase (decrease) in cash, cash equivalents and restricted cash 98,000,000 251,000,000 255,000,000
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 667,000,000 [1] 416,000,000 [1] 161,000,000
Cash, Cash Equivalents and Restricted Cash at End of period(1) [1] $ 765,000,000 $ 667,000,000 $ 416,000,000
[1] Includes $9 million, $9 million and $26 million of restricted cash as of December 31, 2018, 2017 and 2016, respectively, that were included in Other current assets on the Consolidated Balance Sheets.